SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending sharply lower after announcing that Marvell canceled all purchase orders inherited from its acquisition of Celestial AI due to an alleged breach of confidentiality. Investors and community members are expressing significant frustration over management's handling of the disclosure, leading to widespread speculation about the company's future contracts and immediate valuation.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently a focal point for investors as they await topline Phase 3 data from the HAELO trial, which the community sees as a potential validation for their in vivo CRISPR platform. Traders are actively debating the high short interest and the stock's susceptibility to a squeeze, with many weighing the clinical promise of a functional HAE cure against the broader volatility affecting the biotech sector.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending as investors weigh strong AI and automotive growth potential against near-term headwinds like supply chain constraints and cautious analyst sentiment. The stock is a primary focus for the community, which remains divided on whether the current price represents a buying opportunity or a deeper structural decline.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is experiencing significant bullish momentum driven by heavy short interest and mounting anticipation for its acquisition of Northern Data, which effectively expands its cloud and GPU infrastructure. The community is actively discussing a potential short squeeze, citing record-high short interest and strong backing from strategic partner Tether as catalysts for a potential rally.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is experiencing significant market movement driven by speculative interest in its shift toward custom AI chip design and high-performance server CPUs. Community discussions are split between euphoria over its long-term potential as an AI infrastructure backbone and intense debate regarding its valuation, with many traders actively debating the merits of aggressive shorting versus holding for a potential parabolic breakout.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is drawing significant investor interest as it approaches a high-profile oral presentation of pancreatic cancer data at Digestive Disease Week, which the community views as a critical catalyst for the stock. Traders are actively accumulating shares, citing strong scientific momentum and the company's progress in expanding global clinical trials.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares is experiencing massive volatility and bullish momentum driven by a strong semiconductor sector rally, fueled by earnings optimism and ongoing AI infrastructure spending. Investors are actively debating whether the current parabolic price action signifies a sustainable super-cycle or a speculative bubble, leading to intense sentiment clashes between bullish 'diamond hands' and traders betting on a sharp mean reversion.

Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and Lucas Pelkmans on December 19, 2006 and is headquartered in San Mateo, CA.

Sagimet Biosciences Inc - Ordinary Shares - Series A

Sagimet Biosciences Inc

Sagimet Biosciences is currently seeing significant investor attention driven by positive Phase 3 acne data and the potential for its FASN inhibitor denifanstat as a cornerstone MASH treatment. The community is actively debating the company's valuation, the strategic shift toward combination therapies, and the high probability of a future buyout given the surge in M&A activity within the metabolic disease sector.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

The Direxion Daily Semiconductor Bear 3X Shares (SOXS) is seeing intense volatility and record-breaking volume as traders debate whether the semiconductor sector's prolonged winning streak represents an unsustainable AI bubble or a resilient super-cycle. Community sentiment remains deeply polarized between aggressive short-sellers betting on a mean reversion and bulls who argue that relentless momentum and capital rotation into chip-related infrastructure make shorting the sector a high-risk trade.

X-Energy, Inc. operates as an energy company The firm focuses on modular nuclear reactors and fuel technology for clean energy generation. The company was founded by Kam Ghaffarian and Eben Mulder on 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-energy Inc

X-energy is generating significant investor buzz as it makes its market debut, with the community highlighting its strategic backing from major players like Amazon and Dow to address the surging energy demands of AI data centers. Traders are actively debating the company's valuation and long-term potential compared to other modular nuclear reactor peers, fueled by high initial demand and its positioning as a key player in the clean energy infrastructure space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Investors Undervaluing VEON (VEON) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

VEON (NASDAQ:VEON) Upgraded to Strong-Buy at Rothschild & Co Redburn

Rothschild & Co Redburn upgraded VEON to a "strong-buy" rating and set a $74.00 price objective for the company in a research report on Thursday...

VEON Ltd. (NASDAQ:VEON) Given Consensus Rating of "Buy" by Analysts

Shares of VEON Ltd. (NASDAQ:VEON - Get Free Report) have earned an average rating of "Buy" from the five analysts that are currently covering the company, Marketbeat Ratings reports. One investment...

How Much Upside is Left in VEON (VEON)? Wall Street Analysts Think 62.1%

The average of price targets set by Wall Street analysts indicates a potential upside of 62.1% in VEON (VEON). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Is VEON (VEON) Stock Undervalued Right Now?

JPMorgan Chase & Co. Raises Holdings in VEON Ltd. $VEON

JPMorgan Chase & Co. lifted its position in shares of VEON Ltd. (NASDAQ:VEON - Free Report) by 84.2% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 102,827 shares of the Wireless communications provider's stock after acquiring an additional 47,000 shares du...

EXCLUSIVE: VEON Bets on Sovereign AI CEO Says Local AI Models Are Next Big Profit Driver

In a Benzinga exclusive, VEON's CEO says sovereign AI for developing markets is a gap hyperscalers have largely ignored and an opportunity for VEON.read more...

Shah Capital Management Raises Stock Holdings in VEON Ltd. $VEON

Shah Capital Management grew its holdings in shares of VEON Ltd. (NASDAQ:VEON - Free Report) by 1.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The...

Dubai and New York, March 13, 2026 – VEON Ltd. (NASDAQ: VEON), a global digital operator, today announced strong financial and operating results for the fourth quarter and full year ended December 31, 2025.Key Highlights – Fourth Quarter 2025<ul><li>Total revenue grew 17.4% year-on-year (“YoY”) to USD 1,171 million.</li><li>EBITDA increased 29.1% YoY to USD 527 million, with EBITDA margin expanding 410 bps to 45.0%.</li><li>Digital revenues grew 84.1% YoY to USD 235 million, accounting for 20.1% of Group revenue.</li><li>Financial services revenues rose 28.1% YoY to USD 120 million.</li></ul>Key Highlights – Full Year 2025<ul><li>Total revenue increased 9.9% YoY to USD 4,399 million.</li><li>EBITDA rose 18.8% YoY to USD 2,009 million, with EBITDA margin expanding 350 bps to 45.7%.</li><li>Digital revenues grew 62.5% YoY to USD 759 million, representing 17.3% of Group revenue. Digital EBITDA was USD 207 million, reflecting an EBITDA margin of 27.3%.</li><li>Financial services revenues grew 34.3% YoY to USD 425 million.</li><li>Equity free cash flow after leases and licenses reached USD 624 million.</li><li>Capex amounted to USD 930 million, with LTM capex intensity of 21.2% (16.6% excluding Ukraine).</li><li>Total cash, cash equivalents and deposits stood at USD 1,734 million, including USD 557 million at headquarters.</li><li>Net debt (excluding lease liabilities) to EBITDA improved to 1.09x.</li></ul>Capital Allocation and Strategic DevelopmentsVEON maintained disciplined capital allocation, completing its first USD 100 million buyback program (2.14 million ADSs repurchased), and launching a second program on November 14, 2025 (614.5K ADSs repurchased for USD 32.5 million, plus USD 3 million of 2027 Notes, as of 10 March 2026). VEON has adopted a policy framework targeting at least USD 100 million in annual share repurchases, subject to market conditions and Board approval. VEON intends to implement this framework for future buyback programs upon completion of the current USD 100 million program, with all shares repurchased under such future programs to be cancelled.In March 2026, VEON reached an agreement with the Dhabi Group regarding historical shareholder claims, and will welcome His Highness Sheikh Nahyan bin Mubarak Al Nahyan, as a shareholder in the Company.Other milestones include:<ul><li>Successful secondary public offering of Kyivstar shares, raising USD 140 million net proceeds and expanding the investor base.</li><li>Acquisition of Tabletki.ua, Ukraine’s leading online healthcare marketplace, for USD 160 million, expanding digital healthcare offerings.</li><li>Transfer of VEON’s ADS listing to the Nasdaq Global Select Market and inclusion in the S&amp;P Global Broad Market Index and MSCI Ukraine Index.</li><li>Ongoing progress toward acquiring TPL Insurance Limited in Pakistan to bolster digital financial services (expected close mid-2026, subject to approvals).</li><li>Jazz securing largest allocation with 190 MHz in Pakistan’s mobile spectrum auction in March 2026, reinforcing Jazz’s network leadership and service innovation&nbsp;&nbsp;&nbsp; &nbsp;</li></ul>2026 OutlookFor 2026, VEON expects:<ul><li>Total revenue growth of 9%–12% YoY in USD terms</li><li>EBITDA growth of 7%–10% YoY in USD terms</li><li>Capex intensity (excluding Ukraine) of 14%–16% &nbsp;</li></ul>Commenting on the results, VEON Group CEO Kaan Terzioglu said“2025 marked a pivotal inflection point for VEON as a digital operator. For the first time, digital service customers surpassed traditional connectivity subscribers. Resilient core execution, explosive digital growth, especially in financial services, and rigorous cost discipline delivered revenue and EBITDA ahead of forecasts, continuing our track record of keeping the promises we make to investors. Strategic moves like acquiring ride hailing and delivery company Uklon, pharmaceutical and health products marketplace Tabletki.ua, advancing the planned acquisitions of TPL Insurance in Pakistan and classifieds business OLX in Kazakhstan (awaiting regulatory approvals), expanding our Starlink Direct-to-Cell partnership, and strengthening our capital markets profile position us strongly for sustained value creation.”Additional information<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=npp_7UwNvrzhVpV1ULTeK6prqP8yFJjFR17-7H4h4Ky9afIrx_FJAriHv2GxVlpvBZjgYFRgwp8Q_MQX9_dqlPjIGvolyVrUy-PNJCXqvPuvVpqzUdRW_wDKmQ0CCj_3OJjuS8Yn-9bHWfmhBDXDCM7_lyxVd2WABpFSUO-BnZs=">View the full FY25 Earnings Release&nbsp;</a> <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=npp_7UwNvrzhVpV1ULTeK2Y81_B6oMzn7RRdZkO-sAUh5EBPsUMAjHqkmROqufqMd6OyVe93UsH1q9gm1lmsBafsAVCtcoKAo6b2eljkOFDkBpaCF6w8TKD3a225F69C9XjbepDTmJTJQ4EClRsclw==">View FY25 Results Presentation</a> <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=npp_7UwNvrzhVpV1ULTeKzsaCj76GODZ9CNEWzXnatvcMQLoBibfQT_0Mjnbc5BeuDl_yqyw2XA6rAGp755AGBWCumZrBXtpj0-8O86aKX44h6b7WhCLQ6hvum5h_5pl">View FY25 Factbook</a>FY25 results conference callVEON will also host a results conference call with senior management at 16:00 GST (13:00 CET, 8:00 ET) today.To register and access the event, please click here or copy and paste this link to the address bar of your browser:&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=MnkC1VpHa1uVerHuBM4bh3cOh9NnBPgUnNkw1HvMH1A-uwM9vyvFwf2BOx5VcCFmtBeZj7I-dW8B3gV3hdNybaPK8RgKrKbnXFpyWisKBP0lyokJBQPFdUbYbpVrqFknhdAZnGcGFHHwgJhIYSWLoEuSJH2oK3Ma3_hD37yCI2DxmEGFqcemGXvGd9msgbe2RtNrPxm6go8XqydRiJACwxFrrzzsP9iz-xtpsXhO0FlC0d_ogNa0oVlA0apV29qa">https://veon-fy25-and-4q25-results-presentation.open-exchange.net/registration</a>Once registered, you will receive registration confirmation on the email address mentioned during registration with the link to access the webcast and dial-in details to listen to the conference call over the phone.&nbsp;We strongly encourage you to watch the event through the webcast link, but if you prefer to dial in, then please use the dial-in details.&nbsp; Join the Conversation Live&nbsp; In addition to the webcast, the conference call will also be livestreamed on YouTube. This option allows you to follow the discussion in real time from any device without the need for registration or dial-in details. Simply click here or copy and paste this link to the address bar of your browser:&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=MnkC1VpHa1uVerHuBM4bh3X_Swh9mXEfrHtX95ijzeYrohjkKt4MnlzNYtDrpS-9QEo0ksuTtT3k1s3is2r5-_G3LfMN8dClmVKIY_Sy4tI-nYWlwiw5vhQ2_uemYkrfOj2yYWKBHgHNmZ3uaCDyTA==">https://www.youtube.com/live/9JiE8saO38s</a> Q&amp;A&nbsp;If you want to participate in the Q&amp;A session, we ask that you select the ‘Yes' option on the ‘Will you be asking questions live on the call?’ dropdown. That will bring you to a page where you can join the Q&amp;A room by clicking 'Connect to meeting’.You will be brought into a zoom webinar where you can listen to the presentation and once Q&amp;A begins, if you have a question, please use the ‘raise hand button’ on the bottom of your zoom screen. When it is your turn to speak, the moderator will announce your name as well as sending a message to your screen asking you to confirm you want to talk. Once accepted, please unmute your mic and ask your question.You can also submit your questions prior the webcast event to VEON Investor Relations at&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=xWQ9JAsE4bGIB4LcnFUsVq83EI0_9rdbIvHA0FyCJPZkXbhziCNrky5Agk7ZQec7ReEfs8Im6KAUn7MSVhoD2Q==">ir@veon.com</a>.&nbsp;About VEONVEON is a digital operator that provides converged connectivity and digital services to nearly 150 million connectivity and over 135 million digital users. Operating across five countries that are home to more than 6% of the world’s population, VEON is transforming lives through technology-driven services that empower individuals and drive economic growth. VEON is listed on NASDAQ. For more information, visit: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=MnkC1VpHa1uVerHuBM4bh8CsH1WSc_SNsYIxcX8LCkK9R8peTSx2GP9yiEQzPlwuKCckiTLKrpk9NyhGA8uzXNcjNOn-wn7naWP_GfB2pAA=">https://www.veon.com</a>.Notice to readerVEON's results and other financial information presented in this document are preliminary and subject to financial closing procedures that have not yet been completed, and are, therefore, subject to change.This document contains “forward-looking statements,” as the phrase is defined in Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, statements relating to VEON’s future operating results, targets, or financial positions. Forward-looking statements are not historical facts, and are inherently subject to risks and uncertainties, many of which VEON cannot predict with accuracy and some of which VEON might not anticipate. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements. There are numerous risks, uncertainties that could cause actual results and performance to differ materially from those expressed by such statements, such as those discussed in the section entitled “Risk Factors” in VEON’s 2024 Form 20-F filed with the SEC on April 25, 2025 and other public filings made by VEON with the SEC. The forward-looking statements contained in this release speak only as of the date of this release. VEON does not undertake to publicly update, except as required by U.S. federal securities laws, any forward-looking statement to reflect events or circumstances after such dates or to reflect the occurrence of unanticipated events.See “Disclaimer and Notice to Readers” in our full 4Q25 Earnings Release for a more fulsome description of the above.Contact InformationVEON Investor Relations <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=xWQ9JAsE4bGIB4LcnFUsVvFS5QBsLqsNmoxUSJPl-odFz_PY9WBAFg-fW_s-ZalamQWs0uqXBjaASK2WZhLKmg==">ir@veon.com</a>Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

VEON Delivers Record Digital Growth: 4Q25 Digital Revenues Grow 84% to 20.1% of Total, Driving 17% Revenue and 29% EBITDA Growth in 4Q25

VEON 2025: Revenue up 9.9%, EBITDA up 18.8%. Digital growth fuels strong 2026 outlook.

Others

VEON (NASDAQ:VEON) Upgraded to Strong-Buy at Zacks Research

Zacks Research upgraded shares of VEON from a "hold" rating to a "strong-buy" rating in a research report on Thursday...

This account has been verified as an official VEON representative.

Verified Account

VEON_Official

VEON Ltd. is a holding company, which engages in the provision of connectivity and digital services. It operates through the following geographical segments: Pakistan, Ukraine, Kazakhstan, Uzbekistan, and Bangladesh. Additionally, the company reports its operations under Other, which includes activities in Kyrgyzstan, and HQ and eliminations, which covers management-related transactions. The company was founded by Dmitriy Borisovich Zimin and Augie K. Fabela II in 1992 and is headquartered in Dubai, United Arab Emirates.

VEON
VEON Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VEON News

VEONVEON Ltd